Worldwide outreach for a global challenge: Brucellosis Vaccine Prize presented at scientific events around the world

Since applications opened at the Brucellosis International Research Conference late last year, the Brucellosis Vaccine Prize competition has been presented at a number of key scientific events across the globe. Funded by AgResults and implemented by GALVmed, the US $30 million competition invites vaccine developers to submit their proposals for – and ultimately develop – a suitable vaccine that is efficacious, safe and viable for use against Brucella melitensis in small ruminants across the developing world.

Last month, the competition was showcased at the Veterinary Vaccinology Network’s annual conference – and GALVmed CEO Peter Jeffries presented details to a group of researchers at a Biotechnology and Biological Sciences Research Council (BBSRC) meeting on zoonotic diseases. Here, Peter outlines the purpose and nature of the competition – the first of its kind in animal health.

The Brucellosis Vaccine Prize team will be present at a number of other events throughout the year, including next week’s Animal Health Investment Europe Forum, taking place in London on 22nd and 23rd February. For more information on the event schedule or the competition in general, please email brucellosis@galvmed.org.